KEY TRENDS • Oxfam India's 2023 India Supplement report on poverty and inequality in India reveals that the gap between the rich and the poor is widening. Following the pandemic in 2019, the bottom 50 per cent of the population have continued to see their wealth chipped away. By 2020, their income share was estimated to have fallen to only 13 per cent of the national income and have less than 3...
More »SEARCH RESULT
Total Matching Records found : 55
Maiden pharma, under WHO scanner for Gambia kids' deaths, flouted norms in 4 states -Milan Sharma
-IndiaToday.in The Central Drugs Standard Control Organisation (CDSCO) has not yet barred the company from operations in India even as many of its medical products made for Indian use have also been found to be of substandard quality, often flagged by authorities. Ever since Maiden Pharmaceuticals has come under the scanner of the World Health Organisation (WHO) after being flagged for the four cough syrups manufactured in India and exported to Gambia...
More »Drugs board orders probe after WHO’s alert against India-made cough syrups -Sneha Mordani
-IndiaToday.in The Central Drugs Standard Control Organisation has launched a probe after the World Health Organisation (WHO) issued an alert against four India-made cough syrups. The Central Drugs Standard Control Organisation (CDSCO) has launched a probe after the World Health Organisation issued an alert against four India-made cold and cough syrups that have been "potentially linked" with acute kidney injuries and 66 deaths among children in the African country, The Gambia. According to...
More »Most small drug makers aren’t WHO-GMP certified -Priyanka Sharma
-Livemint.com The Centre has started an outreach programme for such SMEs operating in 10 locations Considering that only one-fifth of the small and medium manufacturers of bulk and API (active pharmaceutical ingredient) drugs have been certified under the World Health Organization’s good manufacturing practices, the Centre has launched an outreach programme to establish India as a best-in-class pharma hub, said an official in the know. “As of now, India has around 6,790 SMEs...
More »Is the govt. doing enough for the Jan Aushadhi scheme?
On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...
More »
